The major limitation of this hypothesis generating study is related to the very limited sample size due to stringent exclusions criteria, allowing us to demonstrate that in obese patients without cardiovascular diseases or other cardiovascular risk factors, anti-apoA-1 IgG is associated to obesity and predicts the presence of morphological coronary lesion. This evidence concerns the gene APOA1 and obesity due to melanocortin 4 receptor deficiency.